• 1
    Cancer facts and figures. Atlanta: American Cancer Society, 1999.
  • 2
    Setchell KDR, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone dependent disease. Am J Clin Nutr 1984; 40: 56978.
  • 3
    Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Höckerstedt K, Hämäläinen E, et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992; 41: 3317.
  • 4
    Gittes RF. Carcinoma of the prostate. N Engl J Med 1991; 324: 23645.
  • 5
    Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 1991; 337: 11972000.
  • 6
    Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control 1992; 3: 31322.
  • 7
    Wu AH, Stanczykn FZ, Hendrich S, Murphy PA, Zhang C, Wan P, Pike MC. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 2000; 82(11): 187986.
  • 8
    Seow A, Shi CY, Frankie AA, Hankin JH, Lee HP, Yu MC. Isoflavonoid levels in spot urine are associated with frequency of dietary soy intake in a population-based sample of middle-aged and older Chinese in Singapore. Cancer Epidemiol Biomarkers Prev 1998; 7: 13540.
  • 9
    Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 1989; 49: 185760.
  • 10
    Messina M, Barnes S. The role of soy products in reducing risk of cancer. J Natl Cancer Inst 1991; 83: 5416.
  • 11
    Ingram D, Sanders K, Kolybaba M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 9904.
  • 12
    Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997; 146: 294306.
  • 13
    Adlercreutz H, Gorbach S, Goldin B, Woods MN, Dwyer JT, Höckerstedt K, et al. Diet and urinary estrogen profile in various populations: a preliminary report. Proceedings of the 14th International Meeting on Polycyclic Aromatic Hydrocarbons, 1993.
  • 14
    Burke CW, Anderson DC. Sex hormone binding globulin is an estrogen amplifier. Nature 1972; 240: 3840.
  • 15
    Rosner W. The functions of corticosteroid binding globulin and sex hormone binding globulin: recent advances. Endocrine Rev 1990; 11: 8091.
  • 16
    Adlercruetz H, et al. Isoflavanoids and 2-methyoxyyestradiol: inhibitors of tumor cell growth and angiogenesis. Proc AACR 1995; 35: 6934.
  • 17
    Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, Fotsis T, et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27: 113544.
  • 18
    Fotsis T, Pepper M, Adlecruetz H, Hase T, Monttesano R, Sweiger L. Genestein, a dietary ingested isoflavanoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995; 125: 7907.
  • 19
    Molteni A, Brizio-Molteni L, Persky V. In vitro hormonal effects of soybean isoflavones. J Nutr 1995; 125L: 7516.
  • 20
    Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998; 7(12): 11018.
  • 21
    Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Frankie A. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 3540.
  • 22
    Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994; 151: 1283.
  • 23
    Fotis T, Pepper M, Adlercruetz H, Fleischmann G, Hase T, Montesano R, et al. Genestein, a dietary-derived inhibitor of in-vitro angiogenesis. Proc Natl Acad Sci USA 1993; 90: 26904.
  • 24
    Wang TT, Sathyamoorthy N, Phang JM. Differential effects of genestein on p52 expression and proliferation in MCF-7 cells are concentration-dependent. Pro AICR 1994; 35: A503.
  • 25
    Pagliacci MC, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I. Growth-inhibitory effects of natural phytoestrogens genestein in MCF-7 human breast cancer cells. Eur J Cancer 1994; 30A: 167582.
  • 26
    Adlercreutz H, Houjo H, Higashi A, Fotsis T, Hämäläinen E, Hasegawa T, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093100.
  • 27
    Barnes S. Effect of genestein on in vitro and in vivo models of cancer. J Nutr 1995; 125: s77783.
  • 28
    Schapira DV, Kumar NB, Lyman GH. Obesity, body fat distribution, and sex hormones in breast cancer patients. Cancer 1991; 67(8): 22158.
  • 29
    Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60(3): 33340.
  • 30
    Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1996; 5(1): 6370.
  • 31
    Nagata C, Takatsuka N, Inaba S, Kawakami N, Shmizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J Natl Cancer Inst 1998; 90(23): 18305.
  • 32
    Lu LJ, Cree M, Josyula S, Nagamani M, Grady JJ, Anderson KE. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res 2000; 60(5): 1299305.
  • 33
    Haggans CJ, Travelli ES, Thomas W, Martini MC, Slavin JL. The effect of flax seed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev 2000; 9: 71925.
  • 34
    Lu LJ, Anderson KE, Grady JJ, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000; 60(15): 411221.
  • 35
    Martini MC, Dancisak BB, Haggans CJ, Thomas W, Slavin JL. Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr Cancer 1999; 34(2): 1339.
  • 36
    Hempstock J, Kavanagh JP, George NJR. Growth inhibitors of human prostatic cell lines by phytoestrogens. Proceedings of the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Belgium, 1996.
  • 37
    Schleicher R, Zheng M, Zhang M, Lamartiniere CA. Genestein inhibition in prostate cancer cell growth and metastasis in vivo. Proceedings of the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Belgium, 1996.
  • 38
    Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem 1993; 44: 14753.
  • 39
    Block G, Hartman AM, Dresser CM, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124: 45369.
  • 40
    Harris JA, Benedict FG. A biometric study of basal metabolism in man [no. 279]. Washington, DC: JB Lippincott, The Carnegie Institution of Washington Publication, 1919.
  • 41
    Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142: 1011.
  • 42
    Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 90723.
  • 43
    Partin AW. The free/total prostate-specific antigen test: how should it be used in 1997? Urol Int 1997; 4(3): 189.
  • 44
    Hirano T, Oka K, Akiba M. Antiprol. Effects of synthetic and naturally occurring flavonoids of tumor cells of the human breast carcinoma cell line, ZR 75-1. Res Commun Chem Pathol Pharmacol 1989;64: 6977.
  • 45
    Wang W, Tanaka Y, Han Z, Higuchi CM. Proliferative response of mammary glandular tissue to formononetin. Nutr Cancer 1995; 23: 13140.
  • 46
    Welshons WV, Murphy CS, Koch R, Calaf G, Jordan VC. Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol. Breast Cancer Res Treat 1987; 10: 16975.
  • 47
    Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 1997; 27: 3140.
  • 48
    Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab 1999; 84(11): 401724.
  • 49
    McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, et al. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998; 68(6 Suppl ): S14315.
  • 50
    Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, et al. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 1996; 5(10): 78594.
  • 51
    Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999; 84(1): 1927.
  • 52
    Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999; 84(1): 1927.
  • 53
    Kumar NB, Pow-Sang J, Besterman-Dahan K, Cantor A, Seigne J, Allen K. The specific role of genistein in reducing hormonal and proliferative risk parameters in prostate cancer. Proceedings of the Fourth Annual Symposium on Predictive Oncology and Therapy. International Society for Preventive Oncology, 2000.
  • 54
    Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993; 85: 181927.
  • 55
    Nagamani M, McDonough PG, Ellegood JO, Mahesh VB. Maternal and amniotic fluid steroids throughout human pregnancy. Am J Obstet Gynecol 1979; 134: 67480.
  • 56
    Lu LJ, Lin SN, Grady JJ, Nagamani M, Anderson KE. Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. Nutr Cancer 1996; 26(3): 289302.
  • 57
    Lenton EA, Lawrence GF, Coleman RA, Cooke ID. Individual variation in gonadotrophin and steroid concentrations and in the lengths of the follicular and luteal phases in women with regular menstrual cycles. Clin Reprod Fertil 1983; 2: 14350.
  • 58
    Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975; 55: 699709.
  • 59
    McIntosh JA, Matthews CD, Crocker JM, Broom TJ, Cox LW. Predicting the luteinizing hormone surge: relationship between the duration of the follicular and luteal phases and the length of the human menstrual cycle. Fertil Steril 1980; 34: 12530.
  • 60
    Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 9636.
  • 61
    Parkin DM. Studies of cancer in migrant populations. IARC Sci (Lyon) 1993; 123: 110.
  • 62
    Kelloff GJ, Crowell JA, Steele VE, et al. Progress in cancer chemoprevention: development of diet-derived chemopreventative agents [supplement]. Am Soc Nutr Sci 2000; 467S71S.